Tert-butyl N-[(1R,3R)-1-(4-ethyl-5-methyl-1,3-thiazol-2-yl)-1-hydroxy-4-methylpentan-3-yl]-N-methylcarbamate
C18H32N2O3S — CID 158913107
Data last refreshed: (MolForge compound catalog, from PubChem)
About Tert-butyl N-[(1R,3R)-1-(4-ethyl-5-methyl-1,3-thiazol-2-yl)-1-hydroxy-4-methylpentan-3-yl]-N-methylcarbamate
Tert-butyl N-[(1R,3R)-1-(4-ethyl-5-methyl-1,3-thiazol-2-yl)-1-hydroxy-4-methylpentan-3-yl]-N-methylcarbamate (PubChem CID 158913107) has the molecular formula C18H32N2O3S and a molecular weight of 356.53 g/mol. Its IUPAC name is tert-butyl N-[(1R,3R)-1-(4-ethyl-5-methyl-1,3-thiazol-2-yl)-1-hydroxy-4-methylpentan-3-yl]-N-methylcarbamate.
Molecular Properties
| Compound Name | Tert-butyl N-[(1R,3R)-1-(4-ethyl-5-methyl-1,3-thiazol-2-yl)-1-hydroxy-4-methylpentan-3-yl]-N-methylcarbamate |
|---|---|
| PubChem CID | 158913107 |
| Molecular Formula | C18H32N2O3S |
| Molecular Weight | 356.53 g/mol |
| Exact Mass | 356.21 |
| IUPAC Name | tert-butyl N-[(1R,3R)-1-(4-ethyl-5-methyl-1,3-thiazol-2-yl)-1-hydroxy-4-methylpentan-3-yl]-N-methylcarbamate |
| SMILES | CCc1nc([C@H](O)C[C@H](C(C)C)N(C)C(=O)OC(C)(C)C)sc1C |
| InChI | InChI=1S/C18H32N2O3S/c1-9-13-12(4)24-16(19-13)15(21)10-14(11(2)3)20(8)17(22)23-18(5,6)7/h11,14-15,21H,9-10H2,1-8H3/t14-,15-/m1/s1 |
| InChIKey | HPWYBPCRPKSQLP-HUUCEWRRSA-N |
| XLogP | 4.33 |
| TPSA | 62.66 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 24 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 356.53 |
| LogP ≤ 5 | 4.33 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158913107 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.